Q2 2025 Holdings
Filed 2025-08-13 | 439 holdings | $295.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Altimmune Inc(ALT) | COM NEW | 02155H200 | $50.9K | 13,151 | 0.0% |
| Compass Pathways PLC(CMPS) | SPONSORED ADS | 20451W101 | $58.3K | 20,804 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $61.9K | 6,503 | 0.0% |
| Capricor Therapeutics Inc(CAPR) | COM NEW | 14070B309 | $67.0K | 6,746 | 0.0% |
| Neurogene Inc(NGNE) | COM | 64135M105 | $68.9K | 4,609 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $75.0K | 30,630 | 0.0% |
| Bicycle Therapeutics PLC(BCYC) | SPONSORED ADS | 088786108 | $75.2K | 10,821 | 0.0% |
| Bicara Therapeutics Inc(BCAX) | COM | 055477103 | $75.5K | 8,127 | 0.0% |
| Tourmaline BIO Inc(TRML) | COM | 89157D105 | $75.6K | 4,725 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $75.7K | 9,219 | 0.0% |
| Allogene Therapeutics Inc(ALLO) | COM | 019770106 | $75.9K | 67,166 | 0.0% |
| Metsera Inc | COM | 59267L107 | $77.4K | 2,719 | 0.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $78.1K | 61,459 | 0.0% |
| Xencor Inc(XNCR) | COM | 98401F105 | $78.4K | 9,972 | 0.0% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $79.1K | 10,506 | 0.0% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $79.5K | 5,310 | 0.0% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $79.9K | 6,098 | 0.0% |
| Entrada Therapeutics Inc(TRDA) | COM | 29384C108 | $80.5K | 11,979 | 0.0% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $81.0K | 4,471 | 0.0% |
| Liquidia Corporation(LQDA) | COM NEW | 53635D202 | $81.1K | 6,507 | 0.0% |
| Arbutus Biopharma Corp(ABUS) | COM | 03879J100 | $81.2K | 26,266 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $81.2K | 7,184 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $81.5K | 14,119 | 0.0% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $81.9K | 10,057 | 0.0% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $82.0K | 35,484 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $82.0K | 5,881 | 0.0% |
| Immatics N.v(IMTX) | SHS | N44445109 | $82.4K | 15,315 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $82.5K | 8,813 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $83.1K | 2,926 | 0.0% |
| Tectonic Therapeutic Inc(TECX) | COM | 878972108 | $83.3K | 4,190 | 0.0% |
| Annexon Inc(ANNX) | COM | 03589W102 | $83.3K | 34,698 | 0.0% |
| Mind Medicine Mindmed Inc(BRD1EUR) | COM NEW | 60255C885 | $83.6K | 12,881 | 0.0% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $83.9K | 6,001 | 0.0% |
| Crinetics Pharmaceuticals in(CRNX) | COM | 22663K107 | $84.1K | 2,923 | 0.0% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $84.1K | 2,287 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $84.9K | 13,060 | 0.0% |
| Janux Therapeutics Inc(JANX) | COM | 47103J105 | $85.0K | 3,679 | 0.0% |
| Biohaven LTD(BHVN) | COM | G1110E107 | $85.1K | 6,032 | 0.0% |
| Maze Therapeutics Inc(MAZE) | COM | 578784100 | $85.2K | 6,940 | 0.0% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $85.3K | 6,302 | 0.0% |
| Monte Rosa Therapeutics Inc(GLUE) | COM | 61225M102 | $86.2K | 19,112 | 0.0% |
| Arrivent Biopharma Inc(AVBP) | COM | 04272N102 | $86.6K | 3,979 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $86.8K | 1,988 | 0.0% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $87.1K | 9,103 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $87.2K | 3,290 | 0.0% |
| Belite BIO Inc(BLTE) | SPONSORED ADS | 07782B104 | $87.3K | 1,513 | 0.0% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $87.8K | 4,232 | 0.0% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $87.8K | 2,088 | 0.0% |
| Denali Therapeutics Inc(DNLI) | COM | 24823R105 | $88.1K | 6,300 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $88.4K | 9,513 | 0.0% |